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Background: Both obesity and type 2 diabetes are associated with hypovitaminosis D. The aims of this study were
to investigate the association of serum 25-hydroxy vitamin D (25(OH) D) and parathyroid hormone (PTH)
concentration with body mass index (BMI) in type 2 diabetic patients compared to control subjects and their
predicting role in obesity.
Methods: This cross-sectional study was conducted on 200 subjects (100 type 2 diabetics and 100 healthy
controls). Concentration of 25(OH) D, calcium, phosphorous, parathyroid hormone (PTH), fasting blood glucose,
HbA1c, serum insulin, homeostasis model assessment of insulin resistance (HOMA-IR) was determined in the fasting
samples. Anthropometric measurements including body mass index (BMI) were also measured.
Results: Eighty-five percent of type 2 diabetics and 79% of healthy subjects were suffering from vitamin D
deficiency or insufficiency. Serum concentration of 25(OH) D (22.08 ± 15.20 ng/ml) (r =−0.11, P = 0.04) and calcium
(8.94 ± 0.59 mg/dl) (r =−2.25, P = 0.04) has significant statistically with BMI in type 2 diabetic patients. Serum
concentration of PTH has non-significantly associated with BMI in diabetic patients and healthy subjects.
Conclusion: Serum levels of vitamin D inversely and PTH positively are associated with BMI after adjusted for age,
gender and serum calcium in both type 2 diabetic patients and healthy subjects. These associations were
statistically significant for serum concentration of vitamin D and calcium only in diabetic patients. So the status of
vitamin D is considered as an important factor in type 2 diabetic patients.
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Nowadays we know obesity not only as a simple disease
but also a most common and important risk factor of
chronic disease such as diabetes, hyperlipidemia, can-
cers, cardiovascular disease and osteoarthritis [1]. Obes-
ity is one of returnable environmental risk factor
because it is created and treated with changes in life
style. The incidence of obesity and overweight is rapidly
increasing worldwide. World Health Organization
(WHO) reported that the global prevalence of obesity* Correspondence: ehsaneh_taheri@yahoo.com
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reproduction in any medium, provided the orwill be increased from 350 million obese and 1 billion
overweight [2] in to 2.16 billion overweight and 1.12 bil-
lion obese individuals in 2030. In Iran, there are 24.5
million obese and overweight people which are almost
30% of the population [3].
Vitamin D is a fat–soluble vitamin with hormonal
functions. Vitamin D helps calcium and phosphorus
homeostasis and bone metabolism [4]. Exposure to sun-
light, dietary intake and supplementation with vitamin D
is the main source of vitamin D in human [5]. Further-
more, vitamin D deficiency plays an important role in
many other diseases such as diabetes [6], hypertension
[7], cardiovascular disease [8], immune disorders, osteo-
porosis and cancers [9].td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Baseline demographic and biological
characteristics of the overall population
Variables Type 2 diabetes Control P-value
Age (year) 51.26 ± 11.18 51.55 ± 13.39 0.88
Weight (kg)4 76.96 ± 13.82 73.22 ± 12.98 0.09
BMI (kg/m2) 26.22 ± 9.30 26.26 ± 4.55 0.98
Calcium (mg/dl) 8.94 ± 0.59 9.14 ± 0.53 0.02
Phosphorous (mg/dl) 3.66 ± 0.03 3.70 ± 0.04 0.59
PTH (pmol/l) 4.73 ± 18.80 45.98 ± 26.82 0.10
25(OH) D (ng/ml) 22.08 ± 15.20 22.22 ± 10.03 0.75
FBS (mg/dl) 64.18 ± 174.89 87.69 ± 9.58 <0.01
HbA1c (%) 7.54 ± 1.93 4.97 ± 0.55 <0.01
Insulin (μU/ml) 11.78 ± 8.90 13.67 ± 18.15 0.13
HOMA-IR 89.45 ± 73.92 54.66 ± 31.04 <0.01
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showed that 75.1% of women and 72.1% of men in Iran
have vitamin D deficiency [10]. There are evidences that
circulating levels of 25(OH) D has relationship with obes-
ity. Some studies reported that serum concentration of 1,
25-dihydroxy vitamin D in obese people is higher than
non-obese controls [11-13]. According to these studies, it
is expected that obese subjects have an increased level of
vitamin D. However, there are ample evidences demon-
strating an inverse association between serum level of
vitamin D and obesity [14-17]. Moreover, many studies
suggested that either vitamin D deficiency or obesity is
important risk factors of type 2 diabetes [18-20].
We know that homeostasis of calcium, vitamin D
and PTH is related to each others. Therefore, we
expected that there is association between obesity with
serum concentration of calcium, vitamin D and PTH.
The objective of our study was to determine the relation-
ship between serum levels of vitamin D, PTH and BMI in
type 2 diabetic patients compared to healthy controls.
Methods
In this cross-sectional study, 180 subjects (aged between
20–80 years) including 100 type 2 diabetic patients from
Iranian Diabetes association and National Iranian Oil
Company (NIOC) - Central Hospital and 100 healthy
subjects from staffs of Tehran University of Medical
Sciences Tehran, Iran were selected via random sam-
pling methods. Aged and gender was matched between
two groups. Exclusion criteria were pregnancy, lactation,
use of drugs which may affect lipid profile or calcium
and bone metabolism, chronic disorders of liver and kid-
ney, endocrinology disorders such as hypo- or hyper-
thyroidism or parathyroidism, smoking, insulin injection,
use of anti-convulsion drugs, use of vitamin D and cal-
cium supplementation.
A written informed consent was taken from each par-
ticipant after the full explanations about the study
according to Tehran University of Medical Sciences
Ethics Committee’s procedure.
After an overnight fasting, 10 ml of peripheral blood
was taken. The blood samples were centrifuged at
3000 rpm for 10 min and stored at −20°C. Serum con-
centration of 25(OH) D was measured using chemilu-
minescence method. Serum level of PTH was measured
using RIA kit (CIS Biointernational, France) with normal
range of 8–79 pg/ml. Serum calcium and phosphorus
were analyzed using Pars Azmoon kit (Pars Azmoon Co,
Tehran, Iran). Normal range of calcium and phosphor-
ous were defined to be 8.6 –10.3 mg/dl and 2.5 – 5 mg/dl,
respectively.
Anthropometric data including weight and height were
measured using Seca scale (Seca 725 GmbH & Co.
Hamburg, Germany) while subjects wear light clothesand no shoes in standing posture. The accuracy of
weight and height was 0.1 kg and 0.5 cm, respectively.
Body mass index (BMI) was defined as weight (kg)
divided to height squared (m2). Obesity was defined as
BMI higher than 30 kg /m2. To decrease the seasonal
variability in biochemical determinations, our sampling
was performed between April to June 2010.
Statistical analyses were carried out using statistical
package for social sciences (SPSS) Software, (SPSS Ver-
sion 16, Chicago, USA). Normality of distributions was
confirmed using histogram and Kolmogorov-Smirnov
method before statistical analysis. All continuous vari-
ables are expressed as mean ± SD and categorical vari-
ables as number (%). The student’s t-test was employed
to compare the differences between the mean of con-
tinuous variables. Linear regression with enter method
was used to find association between BMI as dependent
variable and age, serum concentration of calcium, PTH
and vitamin D as explanatory covariates. The P- value
less than 0.05 was considered as statistically significant.
Results
Our study was performed on 180 individuals [52.7% of
type 2 diabetic patients (52.6% men and 47.4% women)
and 47.33% of healthy subjects (52.9% men and 47.1%
women)].
Vitamin D deficiency defined with serum 25 (OH) D
less that 50 nmol/l and serum 25 (OH) D between 50–
75 nmol/l considered as vitamin D insufficiency.
The characteristics of study population including age,
sex, anthropometrics measurements, serum levels of 25
(OH) D, calcium, phosphorous and PTH and glycemic
profile including fasting serum level of glucose, HbA1c,
insulin and HOMA-IR are shown in Table 1. In our
study the prevalence of vitamin D deficiency was 83.3%
among diabetic patients and 75.6% among healthy sub-
jects adjusted for age and sex. Standardized coefficients
Table 2 Pearson’s correlation coefficients r and
standardized regression coefficients β between BMI as
dependent variable and serum 25(OH)D, age, gender,
serum calcium and serum PTH as independent variables
in diabetic patients and controls
Type 2 Diabetes Controls
β r β r
Age (years) 0.06 0.03 0.08 0.03
Gender (M/F) 0.11 1.43 −0.16 −1.51
Serum 25(OH)D (ng/ml) −0.02 −0.11* −0.12 −0.04
Serum calcium (mmol/l) −0.27 −2.81* −0.26 −1.87
Serum PTH (pmol/l) 0.09 0.02 0.04 0.005
* P < 0.05.
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variable in type 2 diabetic patients and controls are
shown in Table 2. In diabetic patients and controls,
serum levels of 25 (OH) D and calcium have inverse re-
lationship with BMI adjusted for age, gender, serum cal-
cium and serum PTH. These associations were
significant in type 2 diabetes.
Standardized β coefficients for PTH and explanatory
variables are presented in Table 3. Serum levels of 25
(OH) D and calcium in type 2 diabetic patients had sta-
tistically significant relationship with serum concentra-
tion of PTH.Discussion
This is the study in Iran determining the relationship be-
tween BMI and vitamin D levels. In our study, the
prevalence of vitamin D deficiency was 82.1% in diabetic
patients and 75.6% in healthy subjects. Iran is one of the
sunny countries in the Middle East with high prevalence
of vitamin D deficiency [10,21,22]. Our findings indi-
cated that serum concentration of 25(OH) D correlated
inversely with body mass index (BMI) in diabetic
patients and healthy controls.Table 3 Pearson’s correlation coefficients r and
standardized regression coefficients β between PTH as
dependent variable and BMI, age, gender, serum calcium
and serum 25(OH) D as independent variables in diabetic
patients versus controls
Type 2 Diabetes Controls
β r β r
Age (years) −0.18 −0.33 −0.09 −0.30
Gender (M/F) 0.22 9.75 0.23 19.82
Serum 25(OH)D (ng/ml) −0.30 −0.41* −0.10 −0.30
Serum calcium (mmol/l) −0.24 −2.25* −0.25 −1.68
BMI (Kg/m2) 0.09 0.31 0.05 0.47
* P < 0.05.Our study indicated that there is a negative relation-
ship between serum levels of 25(OH) D and BMI. There
is a discrepancy in the literature about the association
between obesity and serum level of vitamin D. Several
studies, which published before 1990, indicated that
serum concentrations of 1, 25-OH2-vit D in obese sub-
jects were higher than non-obese controls. These studies
had small sample size below 20 subjects [11-13,23]. The
proposed explanation for increased body fat due to vita-
min D incorporation is presented by Shi and colleagues.
This study reported an increased 1,25OH2vit D intracel-
lular calcium levels in cultured human adiposities due to
vitamin D incorporation. Calcium stimulates lipogenesis
and inhibits lipolysis which results in the accumulation
of body fat [24,25].
However, contrary to these studies, many recent inves-
tigations have found a negative association between
serum level of vitamin D and anthropometric measure-
ments [16-19,24-26]. Furthermore, it has been proposed
that obesity and fat accumulation decrease the bioavail-
ability of vitamin D and trap 25(OH) D in fat tissue.
Worstman, et al. after experimental B-irradiation demon-
strated that concentration of vitamin D3 was 57% lower
in obese than non-obese subjects, whilst there was no
difference in the content of 7-dehydro cholesterol and it’s
conversion to vitamin D3 among obese and non-obese
subjects [26].
Blum, et al. with use of DXA and new liquid chroma-
tography mass spectrometry (LC/MS) method measured
vitamin D in serum and fat tissue in 17 obese men and
women. Results of this investigation showed that fat tis-
sue and serum level of vitamin D3 were inversely corre-
lated both in obese and non-obese subjects [27].
In one study on 66 white Spanish women with BMI =
24–35 kg/m2, overweight and obese women are at
higher risk of vitamin D deficiency, largely due to excess
adiposity rather than inadequate intake [28]. Therefore
body fat must be considered in relation between BMI
and vitamin D. Another study on 250 over weight and
obese adults of different ethnicities demonstrated that
the serum level of vitamin D3 was inversely related to
weight, higher waist circumference, and higher HbA1c,
but not with adipose mass [29]. Pacifico and colleagues
performed a study on 304 Caucasian children with over-
weight/ obesity and 148 healthy subjects with normal
weight. It is disclosed that the serum level of 25(OH) D
is inversely related to total adiposity, components of
metabolic syndrome and hypertension [30]. Further-
more, there are several causes for different results in re-
lation between obesity and vitamin D. Method and
sensitivities of tests in measurement of serum 25(OH)D
and 1,25(OH)2 D are different among studies. The older
studies which show positive association, employed radio
receptor assays for determination of serum level of
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sociation between obesity and vitamin D used modern
radioimmunoassay. However, season have no influence
on the serum level of 1,25(OH)2D as it has on the serum
25(OH) D [31]. We selected the samples of this study in
the wintertime in which insufficient vitamin D synthesis
is very common. Accordingly, latitudes around 40°
North or South have insufficient ultraviolet B (UV-B) ra-
diation in winter time. Iran is located in 25° 39' 47'' lati-
tude. Therefore, in sunny countries especially in Middle
East such as Turkish [32], India [33], Kuwait [34] and
Iran [22], vitamin D deficiency is very common due to
the cultural and religious believes of women who cover
their skin and have a limited sunlight exposure [35,36].
Regarding the relationship between vitamin D defi-
ciency and obesity, there is a hypothesis called "winter
response" which explains how vitamin D deficiency is
causing obesity. This hypothesis explains that how diffi-
cult is to maintain body temperature and energy balance
in a cold environment. Accumulation of fat tissue is
causing to decreased heat conductance from body to en-
vironment [37], and blood circulation of skin [20]. Ultra-
violet (UV) component of the sunlight acts as an
environmental signal for season changes and skin syn-
thesis of vitamin D which acts as a UV-radiation recep-
tor. In this model, decreased concentration of 25 (OH)
D causes to increase the set point of body weight in
hypothalamus. Nowadays, inadequate dietary vitamin D
and sunlight exposure, acts as a situation similar to the
winter with winter response [38].
There are several proposed mechanisms about the in-
verse relationship between vitamin D and BMI. The
studies were performed in vitro have been shown that
vitamin D inhibits expression of uncoupling protein 2
(UCP2) in adipose tissue, differentiation of preadipo-
cytes, synthesis and secretion of lipoprotein lipase [39].
UCPs are a family of inner mitochondrial membrane
transporters having an important role in determination
of resting energy expenditure (REE) [40]. Wong and
colleagues by study on transgenic mice, showed that
the prevalence of obesity was higher in mice with
modified VDR (vitamin D receptor) compared to nor-
mal mice as a result of decreased REE and β-oxidation
of fatty acids (41).
This study had some limitations. The main limitation
of this study was a cross-sectional nature of this study,
with no causality effect to report. The variation in poly-
morphism of DPB and VDR, sunlight exposure and ef-
fect of vitamin D supplementation on the weight gain
are also need to be considered.
In conclusion, a serum level of 25(OH) D has inverse
relationship with BMI among adult population with and
without type 2 diabetes. This relationship was statisti-
cally significant in type 2 diabetic patients. However, it isnot apparent either obesity is a direct consequence of
vitamin D insufficiency or may result in vitamin D
deficiency.
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